PHRENILIN FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phrenilin Forte, and what generic alternatives are available?
Phrenilin Forte is a drug marketed by Valeant and is included in one NDA.
The generic ingredient in PHRENILIN FORTE is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
Summary for PHRENILIN FORTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHRENILIN FORTE at DailyMed |
US Patents and Regulatory Information for PHRENILIN FORTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant | PHRENILIN FORTE | acetaminophen; butalbital | CAPSULE;ORAL | 088831-001 | Jun 19, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |